Immunefi
PrivateLast Round
Series A
Sep 22, 2022
Total Funding Raised
$29.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Immunefi operates in Crypto & Web3 and is based in Singapore. Its latest recorded funding round was a Series A round in September 2022.
Immunefi is a cybersecurity company that provides a crowdsourced bug bounty and security services platform to protect Web3 and blockchain projects from vulnerabilities.
Sector
Crypto & Web3
Verticals
Blockchain Infrastructure, DeFi, Application Security, Smart Contracts, Vulnerability Management
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunefi Comparables
Compare Immunefi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code4rena | 91% | |
| Cantina | 85% | |
| Spearbit | 84% |
For institutional investors. Book with your work email.
Immunefi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2022 | ||||
| Seed | Oct 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immunefi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bitscale Capital | Seed |
| Stratos Technologies | Series A |
| Third Prime | Series A, Seed |
| Lattice Capital Management | Series A |
| Stratos | Series A |
| BR Capital | Seed |
| P2 Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2026
Attending the Digital Asset Summit in London.
- Mar 10, 2026
Protecting over $100 billion in user funds.
For institutional investors. Book with your work email.
Immunefi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immunefi's valuation, stock price, and market status.
Is Immunefi a public or private company?
Immunefi is a private company.
What is the current stock price of Immunefi?
Immunefi is a private company, so its shares have no public market price. Caplight tracks Immunefi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immunefi worth (valuation)?
Valuation information for Immunefi is not publicly available.
Can I buy Immunefi stock?
Immunefi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immunefi's last funding round?
Immunefi's most recent funding round was Series A on September 22, 2022.
Who are the main investors in Immunefi?
Key investors in Immunefi include Electric Capital, Framework Ventures, Blueprint Forest.
Will Immunefi IPO soon?
No public IPO plans have been announced for Immunefi.
How can I track Immunefi secondary market activity?
Caplight tracks bids, offers, and trades in Immunefi's shares on secondary markets.